Landec Corporation (DE) (LNDC)

$7.00

up-down-arrow $-0.14 (-1.96%)

As on 13-Jan-2023 09:30EDT

Market cap

info icon

$259 Mln

Revenue (TTM)

info icon

$278 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2.7

Div. Yield

info icon

0 %

Landec Corporation (DE) (LNDC) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 6.96 High: 7.08

52 Week Range

Low: -- High: --

Liquidityliquidity

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $-125 Mln

  • ROEROE information

    -0.3 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    37.32

  • EV/EBITDAEV/EBITDA information

    -18.3

  • Debt to EquityDebt to Equity information

    0.9

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $--

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    29,595,600

10 Years Aggregate

CFO

$128.92 Mln

EBITDA

$85.88 Mln

Net Profit

$-88.82 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Landec Corporation (DE) (LNDC)
8.0 -8.4 -13.2 -32.6 -12.5 -11.4 -5.2
BSE Sensex*
-9.6 -2.0 3.1 -4.7 5.4 6.0 10.4
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 13-Jan-2023  |  *As on 02-Sep-2026  |  #As on 26-Oct-2023
Company
2022
2021
2020
2019
2018
2017
2016
Landec Corporation (DE) (LNDC)
-41.6 2.3 -4.1 -4.5 -6.0 -8.7 16.7
S&P Small-Cap 600
-17.4 25.3 9.6 20.9 -9.7 11.7 24.7
BSE Sensex
4.4 22.0 15.8 14.4 5.9 27.9 1.9

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Landec Corporation (DE) (LNDC)
7.0 259.3 277.8 -124.4 -32.3 -102.4 -- 2.7
18.1 6,109.1 3,117.6 157.4 14.7 -- 37.3 190.1
41.0 5,252.7 1,105.3 133.3 16.2 32.7 38.3 12.7
209.9 10,424.8 776.6 -191.6 -17.6 -223.4 -- 129.6
76.5 14,974.8 691.8 -696.2 -89.1 -- -- 123.7
110.4 12,310.3 830.8 54.9 3.2 8.1 264.8 17.9
24.7 11,971.8 5,020.0 -199.0 1.6 -3 -- 1.8
286.9 5,591.7 290.5 197.2 82.5 19.9 28.9 5.9
69.7 6,058.9 450.9 138.6 39.1 115.6 50.1 32.1
131.0 8,865.6 431.8 -136.7 -30.8 -30.3 -- 21.5

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Landec Corporation (DE) (LNDC)

Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets in the United States and internationally. It operates through Lifecore,...  Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. Landec Corporation was incorporated in 1986 and is headquartered in Santa Maria, California. 

  • CEO, Pres & Director

    Mr. James G. Hall

  • CEO, Pres & Director

    Mr. James G. Hall

  • Headquarters

    Santa Maria, CA

  • Website

    https://www.landec.com

FAQs for Landec Corporation (DE) (LNDC)

The share price of Landec Corporation (DE) (LNDC) is $7.00 (NASDAQ) as of 13-Jan-2023 09:30 EDT. Landec Corporation (DE) (LNDC) has given a return of -12.53% in the last 3 years.

Since, TTM earnings of Landec Corporation (DE) (LNDC) is negative, P/E ratio is not available.
The P/B ratio of Landec Corporation (DE) (LNDC) is 2.70 times as on 02-Feb-2023, a 65 discount to its peers’ median range of 7.75 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2022
--
--
2021
--
--
2020
--
--
2019
--
--
2018
--
--

The 52-week high and low of Landec Corporation (DE) (LNDC) are Rs -- and Rs -- as of 03-Sep-2026.

Landec Corporation (DE) (LNDC) has a market capitalisation of $ 259 Mln as on 02-Feb-2023. As per SEBI classification, it is a Small Cap company.

Before investing in Landec Corporation (DE) (LNDC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...